Online CME course -LAUNCHING SOON!

Decisions in Diabetes

Stay up-to-date on modern management of type 2 diabetes

Course Details

Price: FREE

Total credits: 4 CME credits

Total Engagement Time: ~3 hours

Course Overview

Course | Decisions in Diabetes

Decisions in Diabetes is an online accredited continuing medical education (CME) program that aims to support physicians in the best practice management of type 2 diabetes. Participants will consolidate their understanding of the modern antidiabetic treatment classes, including latest efficacy and cardiovascular outcomes data, with a particular focus on the GLP-1 receptor agonist class.

  • Module 1 | Understanding the mechanism of action of modern classes of type 2 diabetes treatments and their relationship to one another

    In this module you will learn the basics about the modern antidiabetic treatment classes (DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors) and considerations for choosing an agent after metformin, including:

    • Mode of action by class
    • Top line efficacy by product
    • Practical considerations for prescribing each class
    • Real-world evidence of prescribing each class through example case studies
    • Multifactorial comparison across classes

    After completing this module you should feel confident in the different factors affecting treatment choice in type 2 diabetes, the average HbA1c and weight lowering efficacy of each modern antidiabetic treatment class, their side effect profiles and the typical patient profile that could benefit from treatment with each class, respectively.

  • Module 2 | A multifactorial approach to individualised care

    In this module you will learn about current recommendations and targets for optimal type 2 diabetes management, including insights into the behaviors affecting patient adherence and self-management. This module provides a review of:

    • Basic behavior-change techniques to support patient lifestyle change and treatment adherence
    • Current guidance on HbA1c, weight, and CV risk control targets
    • A stepwise approach to glycemic control
    • GLP-1 receptor agonists as an effective tool for individualized care
    • Long-term HbA1c and weight data for GLP-1 receptor agonists

    After completing this module you should feel confident in having ‘positive’ conversations with patients around intensifying and individualizing treatment after metformin to reach multifactorial health targets, as well as understand how GLP-1 receptor agonists can be employed to support patients in reaching their goals.

  • Module 3 | The impact of CV outcomes trials on T2D treatment decision-making

    In this module you will learn about the link between type 2 diabetes and CV risk, as well as review data from the CV outcomes trials for antidiabetic treatments that have reported in recent years. Content includes:

    • Background to the need for CV outcomes trials in type 2 diabetes
    • Overview of CV outcome trials reported to date and key learning points
    • Side-by-side review of CV outcome trial results
    • Established metrics and strategies for prevention of CV disease in adults
    • Empowering patients to reframe their behaviour around healthier choices to reduce CV risk

    After completing this module you should feel confident in the relationship between and the comorbidities of type 2 diabetes and CV risk, and how positive results from CV outcome trials may impact clinical decision making.

  • Module 4 | Identifying the right patient and initiating GLP-1 receptor agonists

    In this module you will learn more about the GLP-1 receptor agonist class and its benefits, how to counsel a patient when first initiating therapy and long-term efficacy and safety data for marketed agents. Content includes:

    • The typical GLP-1 receptor agonist patient profile
    • Patient pathway review in dual and triple therapy
    • Patient preferences affecting treatment choice and overcoming fear of injections
    • Comparison of efficacy and safety data for GLP-1 receptor agonists
    • Practical initiation information, administration and dosing requirements of GLP-1 receptor agonists

    After completing this module you should feel confident in how to initiate GLP-1 receptor agonist therapy and what to monitor, the differences between marketed GLP-1 receptor agonist agents and their use at multiple stages in the patient pathway.

Pre-Register

A practice-changing CME course

Decisions in Diabetes - developed in collaboration with leading specialists.

Course Disclosures

This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 4 Mainpro+ credits.

Course Sponsorship
This program has received financial support from Novo Nordisk in the form of an educational grant.

Mitigating Potential Bias
The Decisions in Diabetes programme content does not include any specific mention of products or pharmaceutical companies to ensure there is no bias towards specific products or companies.

Review the full disclosure and author COIs here.

The Decisions in Diabetes, made available on https://learn.qxmd.com/courses/decisions-in-diabetes/ and organized by QxMD, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMS-EACCME website have formally been accredited.
Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM.
Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

UEMS logo

Course Authors

  • Damian Edwards

  • Professor Steve Bain

  • Dr Daniel Ngui MD, CCFP, FCFP

  • Dr Alice Cheng MD, FRCPC

  • Dr Yassir Javaid MD

  • Michael A. Nauck Prof. Dr. med. Dr. h.c.

  • Dr Jeffrey Habert MD, CCFP, FCFP

  • Dr John Axler MD, CCFP, FCFP

Relevant to the following healthcare providers:

  • Professions

    • Pharmacist

    • Other

    • Nurse Practitioner

  • Specializations

    • Infectious Disease

    • HIV/AIDS

    • Lipids

  • Countries

    • United States

    • Canada

    • United Kingdom

Course Delivery

Video content icon

Total video time: 91 minutes

Video content is brief and supported by transcripts for when you can't do audio.

Text content icon

Total reading time: 66 minutes

Each chapter takes less than 12 mins to read for on-the-go consumption.

Downloadable content icon

Downloadable Resources: 0

Important charts and graphs are made downloadable so you can access them in your daily practice.

Email reminders icon

Optional email reminders

Choose to take advantage of gentle email reminders to keep you on track and drop you back into where you left off.

Complete at your own pace icon

Complete at your own pace

Though we recommend doing a little every day, complete the course materials whenever is convenient for you.

Autosave icon

Auto-saved progress

Your progress is always auto-saved so you'll be able to easily drop back into the course.

Decisions in Diabetes

Stay up-to-date on modern management of type 2 diabetes

Course Details

Price: FREE

Total credits: 4 CME credits

Total Engagement Time: ~3 hours

Pre-Register